- Home
- GTBP vs IDAI Comparison
GTBP vs IDAI Comparison
Compare GTBP & IDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTBP
- IDAI
- Stock Information
- Founded
- GTBP 1965
- IDAI 2016
- Country
- GTBP United States
- IDAI United States
- Employees
- GTBP N/A
- IDAI N/A
- Industry
- GTBP Biotechnology: Pharmaceutical Preparations
- IDAI Computer Software: Prepackaged Software
- Sector
- GTBP Health Care
- IDAI Technology
- Exchange
- GTBP Nasdaq
- IDAI Nasdaq
- Market Cap
- GTBP 5.6M
- IDAI 5.5M
- IPO Year
- GTBP N/A
- IDAI N/A
- Fundamental
- Price
- GTBP $2.36
- IDAI $1.88
- Analyst Decision
- GTBP Strong Buy
- IDAI
- Analyst Count
- GTBP 1
- IDAI 0
- Target Price
- GTBP $11.00
- IDAI N/A
- AVG Volume (30 Days)
- GTBP 33.2K
- IDAI 73.9K
- Earning Date
- GTBP 05-14-2025
- IDAI 05-13-2025
- Dividend Yield
- GTBP N/A
- IDAI N/A
- EPS Growth
- GTBP N/A
- IDAI N/A
- EPS
- GTBP N/A
- IDAI N/A
- Revenue
- GTBP N/A
- IDAI $3,082,348.00
- Revenue This Year
- GTBP N/A
- IDAI $66.11
- Revenue Next Year
- GTBP N/A
- IDAI N/A
- P/E Ratio
- GTBP N/A
- IDAI N/A
- Revenue Growth
- GTBP N/A
- IDAI N/A
- 52 Week Low
- GTBP $1.72
- IDAI $0.15
- 52 Week High
- GTBP $10.66
- IDAI $8.96
- Technical
- Relative Strength Index (RSI)
- GTBP 50.10
- IDAI 38.52
- Support Level
- GTBP $2.10
- IDAI $1.73
- Resistance Level
- GTBP $2.45
- IDAI $2.16
- Average True Range (ATR)
- GTBP 0.18
- IDAI 0.26
- MACD
- GTBP -0.01
- IDAI 0.01
- Stochastic Oscillator
- GTBP 56.43
- IDAI 17.31
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.
About IDAI T Stamp Inc.
T Stamp Inc develops and markets identity authentication software solutions for enterprise partners and peer-to-peer markets. The company is engaged in developing proprietary artificial intelligence-powered solutions; researching and leveraging biometric science, cryptography, and data mining to deliver insightful identity & trust predictions while identifying and defending against fraudulent identity attacks, protecting sensitive user information, and extending the reach of digital services through accessibility.